Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
NEW YORK – Women with heavy or prolonged periods benefit from treatment with an oral contraceptive formulation that combines step-down estradiol valerate with step-up dienogest, a report in…
NEW YORK (Reuters Health) – Discontinuing clopidogrel before abdominal operation — whether elective or emergent — may not be necessary, a New York team advises. When discontinuation is…
NEW YORK (Reuters Health) – Screening pregnant women for chlamydia using urine samples is just as accurate as when cervical secretions are used, suggests a new study published…
NEW YORK (Reuters Health) – Hydrocortisone therapy may lower the risk of nosocomial pneumonia in severe trauma patients, according to new research from France. The study also found…
NEW YORK (Reuters Health) – A coronary artery bypass graft (CABG) is the best choice for patients with multivessel coronary artery disease who are also diabetic, according to…
NEW YORK (Reuters Health) – Contrary to prior assumptions, prolongation of atrioventricular conduction in fetuses exposed to maternal anti-Ro antibodies does not predict progression to complete atrioventricular block…
NEW YORK (Reuters Health) – For abortion in the second trimester performed for fetal anomalies or fetal death, dilation and evacuation (D&E) is considerably safer than the labor-induction…
NEW YORK (Reuter Health) – With the availability of more sensitive troponin I assays, lowering the diagnostic threshold for detection of myocardial necrosis from 0.20 to 0.05 ng/mL…
NEW YORK (Reuters Health) – Inflammatory bowel disease (IBD) activity is an independent risk factor for the development of venous thromboembolic events (VTEs). That’s one of the findings…
NEW YORK (Reuters Health) – A coronary stent incorporating a polytetrafluoroethylene membrane does not live up to expectations in the treatment of diseased aortocoronary saphenous vein grafts, investigators…
